Scinai Immunotherapeutics

community rating (0 votes):

Description

Scinai Immunotherapeutics Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases.

website

Reviews

No Reviews Yet

Be the first to review one of our webinars!

Upcoming Webinars

There are no upcoming webinars on this topic or publisher.

Previous Webinars

Healthcare > Clinical Trials

SCINAI: 2023 In Review and 2024 Plans

CEO Amir Reichman will review Scinai’s 2023 accomplishments and discuss 2024 plans, including bringing Scinai’s anti-IL-17 VHH antibody (‘NanoAb’) innovative psoriasis treatment into clinical trials by the end of 2024.